Speech-Language Pathologists in Wexford, PA Accepting Medicare
83 Speech-Language Pathologists found. Showing 81 - 83
 Ms. Cassandra Lynne Turic, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11279 Perry Hwy, Suite 110, Wexford, PA 15090 Phone: 724-933-9264 |
Mrs. Kristen Wright, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5000 Stonewood Dr, Wexford, PA 15090 Phone: 724-940-7660 Fax: 724-940-7699 |
Haley Beth Gottlieb, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12300 Perry Hwy, Wexford, PA 15090 Phone: 724-933-4673 |
News Archive
On-site pathology evaluations cut operating time, reduce costs of breast cancer care
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.
Study finds wide racial, geographic health care disparities among Medicare beneficiaries
Race and place of residence can have a significant effect on the quality of care a Medicare beneficiary receives, according to a report released Thursday by the Robert Wood Johnson Foundation, the New York Times reports.
Study revolutionizes treatment principles for functional mitral regurgitation
For years now, cardiology experts have been arguing about how to determine the degree of severity in patients with functional mitral regurgitation and, hence, to assess when it is necessary to operate on the valve.
Proposed settlement does not cover underpaying professional provider claims: Federal court
A federal court in New York, overseeing a proposed class action settlement against United Healthcare for underpaying professional provider claims, has confirmed that the settlement does not cover claims for services and supplies rendered by facilities.
Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma and refractory advanced colorectal cancer.
› Verified 3 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Audiologists
Podiatrists